| Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: a review of current evidence SJ Klempner, D Fabrizio, S Bane, M Reinhart, T Peoples, SM Ali, ... The oncologist 25 (1), e147-e159, 2020 | 280 | 2020 |
| Comprehensive assessment of immuno-oncology biomarkers in adenocarcinoma, urothelial carcinoma, and squamous-cell carcinoma of the bladder A Necchi, R Madison, D Raggi, JM Jacob, G Bratslavsky, O Shapiro, ... European Urology 77 (4), 548-556, 2020 | 43 | 2020 |
| Genomic characterization of testicular germ cell tumors relapsing after chemotherapy A Necchi, G Bratslavsky, RJ Corona, JH Chung, SZ Millis, JA Elvin, ... European urology focus 6 (1), 122-130, 2020 | 42 | 2020 |
| Genomic features of metastatic testicular sex cord stromal tumors A Necchi, G Bratslavsky, O Shapiro, JA Elvin, JA Vergilio, JK Killian, ... European Urology Focus 5 (5), 748-755, 2019 | 30 | 2019 |
| Organizational reference data and entitlement system D Oxenstierna, P Reddy, D Rutter, U Subramanian, JM Taylor US Patent 7,774,365, 2010 | 23 | 2010 |
| Biomarkers in breast cancer: An integrated analysis of comprehensive genomic profiling and Pd‐L1 immunohistochemistry biomarkers in 312 patients with breast cancer RSP Huang, X Li, J Haberberger, E Sokol, E Severson, DL Duncan, ... The oncologist 25 (11), 943-953, 2020 | 19 | 2020 |
| Genomic profiling of circulating tumor DNA from cerebrospinal fluid to guide clinical decision making for patients with primary and metastatic brain tumors LA Ramkissoon, W Pegram, J Haberberger, N Danziger, G Lesser, ... Frontiers in Neurology 11, 544680, 2020 | 19 | 2020 |
| Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions RW Madison, SV Gupta, YY Elamin, DI Lin, SK Pal, A Necchi, VA Miller, ... BJU international 125 (5), 739-746, 2020 | 19 | 2020 |
| Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers A Rankin, A Johnson, A Roos, G Kannan, J Knipstein, N Britt, ... The Oncologist 26 (1), e153-e163, 2021 | 17 | 2021 |
| Landscape of biomarkers in non-small cell lung cancer using comprehensive genomic profiling and PD-L1 immunohistochemistry RSP Huang, E Severson, J Haberberger, DL Duncan, A Hemmerich, ... Pathology and Oncology Research 27, 592997, 2021 | 16 | 2021 |
| Rapid response to lorlatinib in a patient with tfg-ros1 fusion positive inflammatory myofibroblastic tumor of the chest wall metastatic to the brain and refractory to First and … B Carcamo, R Bista, H Wilson, P Reddy, J Pacheco Journal of pediatric hematology/oncology 43 (5), e718-e722, 2021 | 10 | 2021 |
| Assessment of antibiotics prescription in surgical prophylaxis in a teaching hospital MG Gandage, PN Reddy, SB Shirsand, SH Ali, B Kalyani, VM Jeevangi RGUHS J Pharm Sci 3 (1), 67-72, 2013 | 9 | 2013 |
| Budget impact analysis of comprehensive genomic profiling in patients with advanced non–small-cell lung cancer MJ Harvey, R Cunningham, B Sawchyn, M Montesion, P Reddy, ... JCO Precision Oncology 5, 1611-1624, 2021 | 8 | 2021 |
| Comprehensive genomic profiling of histologic subtypes of urethral carcinomas J Jacob, A Necchi, P Grivas, M Hughes, T Sanford, M Mollapour, ... Urologic Oncology: Seminars and Original Investigations 39 (10), 731. e1-731 …, 2021 | 8 | 2021 |
| Assessment of potential drug-drug interactions in the Department of Medicine at Basaweshwara Teaching and General Hospital Gulbarga T Umretiya, PN Reddy Rajiv Gandhi University of Health Sciences J Pharm Sci 5, 90-6, 2015 | 6 | 2015 |
| NTRK1-3 genomic fusions in non-small cell lung cancer (NSCLC) determined by comprehensive genomic profiling SHI Ou, ES Sokol, SE Trabucco, DX Jin, GM Frampton, SL Graziano, ... Annals of Oncology 30, v638, 2019 | 5 | 2019 |
| Extra-mammary Paget’s disease (EMPD) of the skin: A comprehensive genomic profiling (CGP) study. J Tse, JA Elvin, JA Vergilio, JK Killian, N Ngo, DI Lin, S Ramkissoon, ... Journal of Clinical Oncology 37 (15_suppl), 9591-9591, 2019 | 4 | 2019 |
| Immunotherapy predictive biomarkers in metastatic breast cancer (MBC). JS Ross, E Sokol, LA Albacker, GM Frampton, D Pavlick, JA Elvin, ... Journal of Clinical Oncology 37 (15_suppl), 1023-1023, 2019 | 4 | 2019 |
| A Study on Impact of Pharmacist Mediated Patient Counselling on Quality of Life in Astham Patients at a Tertiary Care Hospital S Ahmed PQDT-Global, 2013 | 4 | 2013 |
| RNA sequencing identifies novel NRG1 fusions in solid tumors that lack co-occurring oncogenic drivers E Severson, BR Achyut, M Nesline, S Pabla, RA Previs, G Kannan, ... The Journal of Molecular Diagnostics 25 (7), 454-466, 2023 | 3 | 2023 |
